Treatment of stage D2 hormone refractory carcinoma of the prostate with 5-fluorouracil and Roferon-A: a Southwest Oncology Group study (Q73890193)
Jump to navigation
Jump to search
scientific article published on 01 April 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of stage D2 hormone refractory carcinoma of the prostate with 5-fluorouracil and Roferon-A: a Southwest Oncology Group study |
scientific article published on 01 April 1996 |
Statements
Treatment of stage D2 hormone refractory carcinoma of the prostate with 5-fluorouracil and Roferon-A: a Southwest Oncology Group study (English)
M E Marshall
M Wolf
M O'Rourke
T C Barnett